• 의료법학
• /
• 제25권1호
• /
• pp.3-58
• /
• 2024

It has become a general idea today that the characteristics of medicine should be considered as a basis when discussing a medical personnel's duty of care and whether or not it has been violated, and when discussing its duty of explanation and whether or not it has been fulfilled in medical practice. However, in the discussion of its characteristics, some shortcomings still exist, so the need for a re-discussion has been raised. Firstly, existing discussions on characteristics have failed to comprehensively grasp and explain the characteristics of medical practice. Secondly, in some researchers' arguments, there are discrepancies between the terms used to express characteristics and their conceptual definitions or content. Thirdly, the lack of exemplified cases that reflect the characteristics of medicine - especially Supreme Court precedents - has led some to think negatively about the recognition and reflection of certain characteristics. In my early writings, I have described five characteristics of medical practice: 'conflict in medical goals', 'initiating appropriate medical actions (progression of illness)', 'dynamics of medical intervention (diversity of symptoms)', 'diversity of medical effects', 'inherent risk of medical treatment (invasiveness)'. In this paper, keeping in mind the reasons for the need for reconsideration, I aim to analyze the characteristics of medicine in detail and cite key parts of representative Korean Supreme Court precedents that reflect each characteristic. The characteristics of medicine extracted from this paper are; There are ten factors, including the legitimacy of the essence of medical practice, timeliness of medical execution, dynamics of medical progress, diversity of medical effects, risk of medical invasion, non-uniformity of medical methods, limitations of medical capabilities, intervention of the medical subject, high degree of medical standards, and maldistribution of medical data.

• 대한예방의학회:학술대회논문집
• /
• 대한예방의학회 1994년도 교수 연수회(역학)
• /
• pp.332-335
• /
• 1994

Compared to other variables being considered in therapeutics, patient compliance has long been given minor attention although it affects every aspect of medical care; Limited methodology of compliance measurement, in particular, has hampered major progress in research, and pre-conceptions have been reiterated. However, there is a recent surge in interest derived from new data revealed by reliable methods, i.g. continuous medication (compliance) monitoring. The visualization of dynamics in drug regimen compliance over time offers unique opportunities, both to scientific drug evaluation and therapeutics in medical practice. New perspectives related to the descriptive and explanatory side of the problem are outlined by giving examples from various therapeutic fields.

• 한국의학물리학회지:의학물리
• /
• 제8권1호
• /
• pp.75-82
• /
• 1997

인체의 생리기관의 운동은 매우 복잡하고 불규칙적인 운동을 보이고 있다. 특히 말초 혈관의 운동은 매우 민감하고 복잡한 운동특성을 보이고 있다. 그중에서도 당 (glucose)에 의한 운동은 매우 민감한 변화의 운동을 반응한다. 이런 운동을 분석하기에는 기존의 선형적인 분석방법으로 복잡한 혈류운동을 분석하고 예측하기에는 많은 문제점을 가지고 있다. 그래서 비선형적 운동계의 분석방법인 카오스이론의 시계열분석방법으로 분석하는 것이 적합하다. 이런 맥락으로 본 연구는 당의 주입에 의한 토끼의 말초혈류량의 스칼라적 데이터를 획득하여 시계열분석방법으로 다차원의 벡터로 재정의하여 말초혈관의 혈류운동이 카오스적 운동임을 재확인하고 비선형적분석방법의 적합성을 확인하고자 하였다. 그 결과 당 주입에 따른 혈당치의 변화에 따라 기존의 주파수분석 및 평균치분석에서 차이가 나타나지 않았지만 비선형적분석방법으로 분석한 결과 그 차이를 확인할수 있었고, 말초 혈류의운동이 카오스적현상을 보임을 확인하였다.

• BMB Reports
• /
• 제54권1호
• /
• pp.2-11
• /
• 2021

Antibody-based therapeutics targeting the inhibitory receptors PD-1, PD-L1, or CTLA-4 have shown remarkable clinical progress on several cancers. However, most patients do not benefit from these therapies. Thus, many efforts are being made to identify new immune checkpoint receptor-ligand pathways that are alternative targets for cancer immunotherapies. Nectin and nectin-like molecules are widely expressed on several types of tumor cells and play regulatory roles in T- and NK-cell functions. TIGIT, CD226, CD96 and CD112R on lymphoid cells are a group of immunoglobulin superfamily receptors that interact with Nectin and nectin-like molecules with different affinities. These receptors transmit activating or inhibitory signals upon binding their cognate ligands to the immune cells. The integrated signals formed by their complex interactions contribute to regulating immune-cell functions. Several clinical trials are currently evaluating the efficacy of anti-TIGIT and anti-CD112R blockades for treating patients with solid tumors. However, many questions still need to be answered in order to fully understand the dynamics and functions of these receptor networks. This review addresses the rationale behind targeting TIGIT, CD226, CD96, and CD112R to regulate T- and NK-cell functions and discusses their potential application in cancer immunotherapy.